Andrew Siderowf, MD, MSCE

University of Pennsylvania School of Medicine

Andrew Siderowf, MD, MS, is the Hurtig-Stern Professor of Neurology and the Chief of the Movement Disorders Division at the Penn Perelman School of Medicine, Department of Neurology. He received his MD at Duke University, residency training at the Hospital of the University of Pennsylvania and fellowship training in Movement Disorders and Experimental Therapeutics at the University of Rochester (under Ira Shoulson, MD). Dr. Siderowf’s clinical practice focuses on the diagnosis and management of patients with Parkinson’s disease and related disorders. His research addresses the organization and conduct of clinical trials, particularly the use of biomarkers as outcome measures. Dr. Siderowf had been on the faculty at the Department of Neurology in the University of Pennsylvania, Perelman School of Medicine, from 1998-2012. From 2012-2017, Dr. Siderowf was Medical Director at Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Co. in Philadelphia. At Avid, Dr. Siderowf worked on clinical development of Positron Emission Tomography (PET) ligands for in-life assessment of pathology in neurodegenerative disorders. He returned to Penn in July 2017. Since 2017, Dr. Siderowf has been the director of the UPenn Parkinson’s Disease and Movement Disorders Center (PDMDC) and Chief of the Movement Disorders Division. The PDMDC is one of the leading Centers for Parkinson’s disease and related disorders in the US. The PDMDC is recognized as a Center of Excellence by the Parkinson Foundation, the Cure PSP Foundation and the Lewy Body Dementia Society, and is an awardee of the prestigious Fox/Safra fellowship training program. His research focuses on the organization and conduct of clinical trials. He has leadership roles in a number multi-center clinical research projects related to Parkinson’s disease funded by the NIH (site co-PI for NeuroNEXT), the Michael J Fox Foundation (e.g. PPMI) and Industry. He has served as a standing member of the NIH NSD-K clinical trials study section and a faculty member for the NINDS clinical trials training course. He serves on multiple Data Safety Monitoring Boards for clinical trials. Dr. Siderowf has held a number of administrative roles including chair of the publication committee and the symposium committee for the Parkinson Study Group. At present, he serves on the executive steering committee for the PPMI study, the executive committee of the Parkinson Study Group, on the Congress Scientific Planning Committee for the Movement Disorders Society and the newly-formed Experimental Therapeutics Section of the AAN (R. Griggs, Chair).


NOTE: If no session is listed above, this individual is a Chair or Co-chair of a session(s). Please see the individual session listings found in the Program for a full list of session participants.